<DrugInformationSummary id="CDR0000689968"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about denosumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/denosumab">Denosumab</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000481348">denosumab</TerminologyLink><GlossaryLink ref="CDR0000514443">denosumab</GlossaryLink><USBrandNames><USBrandName>Prolia</USBrandName><USBrandName>Xgeva</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>deh-noh-SOO-mab</TermPronunciation><MediaLink ref="CDR0000718129" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000718128" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=DENOSUMAB&amp;pagesize=20&amp;page=1&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Denosumab</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=DENOSUMAB&amp;pagesize=20&amp;page=1&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title><Para id="_12">Denosumab is approved to treat:</Para><ItemizedList Style="bullet" id="_13"><ListItem><Strong><GlossaryTermRef href="CDR0000752738" dictionary="Cancer.gov" audience="Patient">giant cell tumor</GlossaryTermRef> of the bone</Strong> that cannot be removed by surgery. It is used in adults and in adolescents whose bones have finished growing</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045363" dictionary="Cancer.gov" audience="Patient">hypercalcemia of malignancy</GlossaryTermRef></Strong> that got worse after treatment with <GlossaryTermRef href="CDR0000044817" dictionary="Cancer.gov" audience="Patient">bisphosphonates</GlossaryTermRef><Para id="_14"> These uses are approved for the Xgeva brand of denosumab.</Para></ListItem></ItemizedList>                                                              
  
 <Para id="_4">Denosumab
         is approved to prevent:</Para><ItemizedList Style="bullet" id="_5"><ListItem>	<Strong>broken bones and other bone problems</Strong> caused by <GlossaryTermRef href="CDR0000045793" dictionary="Cancer.gov" audience="Patient">multiple myeloma</GlossaryTermRef> or by <GlossaryTermRef href="CDR0000045301" dictionary="Cancer.gov" audience="Patient">solid tumors</GlossaryTermRef> that have spread to bone. This use is approved for the  Xgeva brand of denosumab</ListItem></ItemizedList><Para id="_9">Denosumab is also approved to increase <GlossaryTermRef href="CDR0000415884" dictionary="Cancer.gov" audience="Patient">bone mass</GlossaryTermRef> in adults who have a high risk of breaking bones. It is used in the following types of cancer:</Para><ItemizedList Style="bullet" id="_10"><ListItem><Strong><GlossaryTermRef href="CDR0000444971" dictionary="Cancer.gov" audience="Patient">breast cancer</GlossaryTermRef></Strong> in women receiving <GlossaryTermRef href="CDR0000044232" dictionary="Cancer.gov" audience="Patient">aromatase inhibitor</GlossaryTermRef> <GlossaryTermRef href="CDR0000044737" dictionary="Cancer.gov" audience="Patient">therapy</GlossaryTermRef></ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000445079" dictionary="Cancer.gov" audience="Patient">prostate cancer</GlossaryTermRef></Strong> in men receiving <GlossaryTermRef href="CDR0000559086" dictionary="Cancer.gov" audience="Patient">androgen deprivation</GlossaryTermRef> therapy<Para id="_15">These uses are approved for the Prolia brand of denosumab.</Para></ListItem></ItemizedList><Para id="_11">Denosumab is also being studied in the treatment of other conditions and types of cancer.</Para></Section><Section id="_About"><Title>More About Denosumab</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/481348">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.32">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a610023.html">Denosumab</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.33"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.34">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2024/breast-cancer-jaw-osteonecrosis-antiresorptive">Jaw Problems Linked to Bone-Modifying Drugs Not as Rare as Once Thought</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies">Monoclonal Antibodies</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C61313">Find Clinical Trials for Denosumab</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2010-11-30</DateFirstPublished><DateLastModified>2024-09-26</DateLastModified></DrugInformationSummary>
